Minimum Ejection Fraction for Hip Arthroplasty
There is no absolute minimum LVEF cutoff that prohibits hip arthroplasty, but patients with LVEF <30% face significantly elevated perioperative risk and require intensive optimization and monitoring, while those with symptomatic heart failure (regardless of LVEF) represent the highest-risk group requiring aggressive preoperative management.
Risk Stratification by LVEF
The 2014 ACC/AHA perioperative guidelines establish that **severely decreased LVEF (<30%) is an independent contributor to perioperative outcome and a long-term risk factor for death in patients undergoing elevated-risk noncardiac surgery** 1. Importantly, survival after surgery for those with LVEF ≤29% is significantly worse than for those with LVEF >29% 1.
Key LVEF Thresholds:
- LVEF <30%: Highest risk category requiring extensive preoperative optimization
- LVEF 30-40%: Intermediate risk with increased mortality compared to normal LVEF 1
- LVEF >40%: Risk of death does not increase notably until LVEF falls below this threshold 1
Critical Distinction: Symptomatic vs. Asymptomatic Dysfunction
The presence of symptomatic heart failure confers higher risk than LVEF alone. A prospective study of 1,005 vascular surgery patients demonstrated 30-day cardiovascular event rates of 1:
- Symptomatic HF: 49% (highest risk)
- Asymptomatic systolic LV dysfunction: 23%
- Asymptomatic diastolic LV dysfunction: 18%
- Normal LV function: 10%
This hierarchy means that a patient with symptomatic HF and LVEF of 35% carries substantially higher risk than an asymptomatic patient with LVEF of 25%.
Hip Arthroplasty-Specific Considerations
Hip arthroplasty, particularly revision procedures, poses unique cardiopulmonary risks due to bone cement implantation syndrome. During femoral prosthesis insertion, embolization of cement-bone marrow debris can cause acute right ventricular dysfunction, with some patients experiencing RVEF decreases ≥10% and mean pulmonary artery pressure increases ≥10 mmHg 2. This additional hemodynamic stress makes preexisting LV dysfunction particularly concerning.
Practical Management Algorithm
For LVEF <30%:
- Mandatory cardiology consultation
- Optimize medical therapy (diuretics, ACE inhibitors/ARBs, beta-blockers)
- Consider delaying surgery if acute decompensation present
- Plan for intensive intraoperative monitoring (consider pulmonary artery catheter)
- Arrange ICU bed postoperatively
For LVEF 30-40%:
- Cardiology consultation recommended
- Ensure euvolemic state preoperatively
- Standard ASA monitoring with arterial line consideration
- Close postoperative monitoring
For LVEF >40% without symptoms:
- Proceed with standard perioperative protocols
- No additional cardiac workup required solely based on LVEF
Common Pitfalls to Avoid
- Do not deny surgery based solely on a low LVEF number - the decision must incorporate symptom status, functional capacity, and urgency of surgery
- Do not assume LVEF >50% means low risk - symptomatic HF with preserved EF still carries significant perioperative mortality 1
- Do not overlook diastolic dysfunction - it independently predicts MACE and prolonged hospital stay 1
- Do not forget right ventricular function - particularly relevant in hip arthroplasty given embolization risk 2
The Bottom Line
While no absolute LVEF cutoff exists, LVEF <30% represents a critical threshold where perioperative mortality substantially increases 1. However, symptomatic heart failure status trumps the numeric LVEF value in risk stratification. The decision to proceed must weigh surgical urgency, optimization potential, and institutional resources for high-risk perioperative management rather than applying an arbitrary LVEF minimum.